The company’s Rx Guardian CD medication monitoring now includes oxymorphone, allowing physicians to compare their patients’ levels with a database of patients who were prescribed oxymorphone for chronic pain and were clinically assessed as adherent.
More Articles on Pain Management:
5 Statistics on Chiropractic Use for Medicare Patients
5 Statistics on Anxiety for Pain Patients at EDs
Chronic Pain Management Costs $635B Annually
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.